Search
forResearch 10 of 1000+
- 544 Alopecia areata lesions show significant changes in immune and keratin biomarkers that correlate with clinical improvement with oral Janus kinase inhibitors PF-06651600 (JAK3) and PF-06700841 (TYK2/JAK1)
- JAK inhibition in the treatment of alopecia areata – a promising new dawn?
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- Systemic treatments for alopecia areata: A systematic review
- New drugs under investigation for the treatment of alopecias
- Janus kinase inhibitors for alopecia areata: a review of clinical data
- Janus Kinase inhibitors in dermatology: a review
- New therapies for alopecia areata
- The role of janus kinases in the treatment of autoimmune skin diseases
- Clinical Trials and Hair Loss
Community 1 of 2
All community results →Learn
— no results
Try a deeper search in learn →